Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q4FY26 scheduled to be held on May 14, 2026 at 05:00 P.M. (IST)
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals has notified exchanges that it will host an earnings conference call for Q4 and FY ended March 31, 2026 on Thursday, May 14, 2026 at 05:00 PM IST. The call is being organized by Ambit Capital and will feature company management including Managing Director Mr. Swapnil Shah, Chairman Mr. Sanjay Majmudar, and Whole Time Director & CFO Mr. Deval Shah. The company has confirmed that an audio recording and transcript of the call will be published on the company website after the event. The filing is pursuant to SEBI LODR Regulation 30, which requires timely disclosure of material events.
This is a standard disclosure informing investors of an upcoming earnings call. No new financial figures or material information are provided in this filing. Investors should note the date and dial-in details if they wish to participate.